Mexico: new links between patents and pharmaceuticals

The so-called Mexican linkage system aims to improve the communication between the Federal Commission for Protection against Health Risks (COFEPRIS), which is the health regulatory agency in Mexico, and the Mexican Institute of Industrial Property (IMPI), in order to prevent the granting of marketing authorisations (MAs) for generic versions of pharmaceutical drugs which might fall within the scope of valid patents.